Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Lia Scribano

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Digestive Diseases and Sciences|March 26, 2024
Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian StudyAnna Maria Carvalhas Gabrielli, Francesca Ferretti, Camilla Maria Monico, et al.
Gut|December 24, 2014
Randomised controlled trial of mesalazine in IBSGiovanni Barbara, Cesare Cremon, Vito Annese, et al.
Lancet (London, England)|April 2, 2019
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority studyByong Duk Ye, Marina Pesegova, Olga Alexeeva, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Frontiers in Medicine|April 28, 2023
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel diseaseMarco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone, et al.
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2021
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in ItalyAlessandro Vitello, Mauro Grova, Daniela Pugliese, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Digestive Diseases and Sciences|March 26, 2024
Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian StudyAnna Maria Carvalhas Gabrielli, Francesca Ferretti, Camilla Maria Monico, et al.
Gut|December 24, 2014
Randomised controlled trial of mesalazine in IBSGiovanni Barbara, Cesare Cremon, Vito Annese, et al.
Lancet (London, England)|April 2, 2019
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority studyByong Duk Ye, Marina Pesegova, Olga Alexeeva, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Frontiers in Medicine|April 28, 2023
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel diseaseMarco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone, et al.
Journal of Crohn'S & Colitis|March 3, 2016
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD StudyLivia Biancone, Alessandro Armuzzi, Maria Lia Scribano, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2021
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in ItalyAlessandro Vitello, Mauro Grova, Daniela Pugliese, et al.
Pageof 4